Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
871 participants
INTERVENTIONAL
2001-01-31
2014-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Docosahexaenoic Acid (DHA) Supplementation in High Risk Pregnancies
NCT04069195
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation Disorders
NCT02336243
Prenatal DHA and Neurofunctional Development
NCT02709239
Effects of Docosahexaenoic Acid (DHA) on Fetal Cardiac Outcomes
NCT01007110
Effects of Prenatal DHA Supplements on Infant Development
NCT00646360
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
300 mg DHA
300 mg DHA
300 mg DHA
Pregnant women were given 300 mg DHA in the last trimester of pregnancy and through the first 3 months of breastfeeding
Placebo
olive oil or high oleic acid sunflower oil placebo
Placebo
Pregnant women in the control group received placebo of either olive oil or high oleic acid sunflower oil during the study period
600 mg DHA
600 mg DHA
600 mg DHA
Pregnant women were given 600 mg DHA in the last trimester of pregnancy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
600 mg DHA
Pregnant women were given 600 mg DHA in the last trimester of pregnancy
300 mg DHA
Pregnant women were given 300 mg DHA in the last trimester of pregnancy and through the first 3 months of breastfeeding
Placebo
Pregnant women in the control group received placebo of either olive oil or high oleic acid sunflower oil during the study period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older
Exclusion Criteria
* presence of cervical cerclage
* placenta previa
* intrauterine infection
* known substance abuse
* multiple fetuses
* current pre-eclampsia
* preexisting diabetes
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
USDA Beltsville Human Nutrition Research Center
FED
Colorado State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mary A Harris, PhD
Role: PRINCIPAL_INVESTIGATOR
Colorado State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver Health Hospitals and Clinics
Denver, Colorado, United States
Colorado State University
Fort Collins, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
00186H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.